Cargando…
Npt2a as a target for treating hyperphosphatemia
Hyperphosphatemia results from an imbalance in phosphate (P(i)) homeostasis. In patients with and without reduced kidney function, hyperphosphatemia is associated with cardiovascular complications. The current mainstays in the management of hyperphosphatemia are oral P(i) binder and dietary P(i) res...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022968/ https://www.ncbi.nlm.nih.gov/pubmed/34994388 http://dx.doi.org/10.1042/BST20211005 |